The idea that sex sells is generally accepted as fact. The idea that the sex of cells is important to biomedical research is not as well-known, but an article co-written by a researcher at the University of Alabama at Birmingham, suggests that the sex of individual cells matters.
The sex of a cell is determined by the presence of sex chromosomes: every cell can be categorized as either male or female. The significance of a cell’s sex is a concept that has been generally overlooked by the research community, but there is now a growing body of evidence that has some researchers examining important implications.”
“Male cells have an X and a Y chromosome, while female cells have two X chromosomes,” said Cathy Fuller, Ph.D., associate professor in the Department of Cell, Developmental and Integrative Biology at UAB. “There is now good reason to consider that studies conducted in male cells will produce results different from those of identical studies using female cell lines. This could have a profound effect on fields such as personalized medicine.”
This month, Fuller, along with colleague Paul Insel, Ph.D., of the departments of Pharmacology and Medicine at the University of California-San Diego, published an editorial in the American Journal of Physiology-Cell Physiology called “I Don’t Know the Question, but Sex is Definitely the Answer!” The editorial comes on the heels of a 2012 decision by the American Physiology Society to require authors to report the sex of the cells lines, biological materials and animals used in their experiments.
Fuller and Insel looked at two articles published in AJP-Cell and one in Nature that laid out the reasons that the APS decision to disclose the sex of cell lines was essential. They wrote that the lessons learned from these articles suggest the APS policy could have an important effect on patient care.
“We have assumed that cells bearing an XY genotype behave the same as cells that are XX, but we don’t really know if that is correct,” said Fuller. “Do T-84 cells, derived from a male colon cancer patient, behave the same as Ht-29 colon cancer cells, derived from a female? And will a colon cancer drug tested in one cell line work in the same fashion in all patients?”
An additional complication, according to Fuller, is that many cell lines frequently used in research are old — some have been around for more than 50 years — and some supposedly male lines have lost the Y chromosome through the many repetitive cell culture cycles.
“As we move closer to the concept of personalized medicine, where drugs and therapies can be tailored for the individual patient, we will need a more complete understanding of the physiology of that patient down to the cellular level,” Fuller said. “A drug that was tested in a cell line without a Y chromosome might not work as well in a patient who does have Y chromosomes. This could help explain why certain drugs work better in some patients than in others.”
Fuller says investigators working on developing drugs such as small molecules and biologics will need to consider that sex differences may underlie differences in responsiveness of different cells used in high-throughput screens, as well as considering the sex of the patient group to whom the drugs are targeted. Sex differences will be particularly important in stem cell-based therapies, such that the sex of both the donor and the recipient should be considered.
She also suspects that other scientific journals will follow suit and require investigators to identify the sex of their cell lines. The good news is that the sex of many of the major cell lines currently in use is known and that information is available to researchers.
UAB faculty recognized nationally for biomedical researchSorge honored as a young leader in the field of pain research and neuroscience by national organization.posted 6 days ago 1033 viewsTwo UAB advisors honored at national levelAcademic advisors from the Collat School of Business and College of Arts and Sciences recognized nationally for their contributions to the improvement of advising services.posted 6 days ago 770 viewsPollocks make list of top nephrology, dialysis professorsUAB professors who developed a new area of translational cardio-renal research are among 15 professors identified as today’s leaders in the field.posted 8 days ago 991 viewsMolecular study points to possible therapy for autoimmune diseaseThe challenge is to stifle the binding of inhibitory antibodies but retain activity of a blood enzyme.posted 13 days ago 1099 viewsRowe named head of UAB Cystic Fibrosis CenterThe CF clinical trials expert will take the reins of the UAB Gregory Fleming James Cystic Fibrosis Center on Aug. 1.posted 13 days ago 2048 viewsOcean acidification to lead the way for food chain changesUAB research shows that phytoplankton, the foundation of all marine life, will experience varied growth rates due to ocean acidification levels during the next century.posted 14 days ago 2440 viewsEarly Childhood Special Education professor awarded 1.25 million grant from U.S. Department of Education1.25 million grant will be used to improve services and results for young children with disabilities and their families.posted 15 days ago 1830 viewsBaby JJ scheduled to have second hypoplastic left heart syndrome surgery TuesdayNarrowing of aortic arch, infant’s otherwise good health prompt physicians to move Baby JJ’s Glenn procedure up one month.posted 15 days ago 1518 viewsFirst-of-its-kind tornado panels installed in Montgomery home
A product designed by UAB engineers to help save lives during natural disasters is approved for use.Joint Commission awards advanced certification in ventricular assist device destination therapy to UABUAB Hospital is the only Disease-Specific Certified program in Alabama and has had no observations or findings by The Joint Commission since joining the certification process.posted 26 days ago 1014 viewsUAB re-verified as a Level I Trauma Center through 2018The American College of Surgeons has again verified UAB as a Level I Trauma Center, a designation held by UAB since 1999.posted 26 days ago 3897 viewsUAB Dentistry Alumni Association honors McCullohThe University of Alabama at Birmingham’s School of Dentistry Alumni Association has named J. Calvin McCulloh, DMD, the recipient of the 2015 H. Moren Fuller Award.posted 27 days ago 811 viewsSingh honored as new ASA FellowUAB’s Karan Singh has been selected as an American Statistical Association Fellow and recognized as a foremost member in the field of statistical science.posted 27 days ago 1012 viewsNew state network to advance women leaders in higher education launched at UABThe new Alabama Network for Women Leaders in Higher Education is part of the American Council on Education’s Women’s Network, a national system of state networks focused on advancing and supporting women in higher education.posted 29 days ago 1681 viewsUAB adds leading surgeon-scientist as head of Department of SurgeryTop physician-scientist tapped to succeed Kirby Bland as chair of the UAB Department of Surgery.posted 29 days ago 1999 viewsUAB researcher wins early-stage investigator award for epigenetics of substance abuse researchA UAB researcher focusing on the epigenetics of drug abuse wins a significant funding award from the National Institutes of Health.posted a while back 933 viewsResearch finds males and females process chronic pain differentlyMale and female mice use different immune cells to process chronic pain, indicating that different therapies for different genders could better target the problem.posted a while back 2644 viewsSchool of Dentistry aims to capitalize on best investment — its peopleThe school aims to continue offering students cutting-edge opportunities by expanding educational programming, enhancing diversity, growing research dollars and broadening its capacity to help Alabama’s underserved.posted a while back 1872 viewsDon’t let summer fun interfere with keeping your peepers protectedEnvironmental factors like pool and ocean water seem harmless, but they can actually affect eye health. UAB experts break down how to stay safe this season.posted a while back 1107 viewsPotential drug lessens neurodegeneration in Parkinson’s disease modelThe drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.posted a while back 3358 views